Both public health systems and pharmaceutical companies must adapt and re-focus on patients

• As people are living longer, there is a disproportionate and unsustainable dependency ratio between those in the workforce and those in retirement.
• Prevention is better than cure, but healthcare services are more focused on curing than preventing illness.
• The pharmaceutical industry must better collaborate with healthcare systems to maximise patients’ access to prevention and treatment.

COVID-19 may still consume much of the attention of the global health community, but the challenges facing providers and innovators beyond the pandemic are massive. Cardiovascular disease (CVD) is the leading cause of death worldwide. It kills more people than all...